Investing.com - Clearpoint Neuro (NASDAQ: CLPT) reported third quarter EPS of $-0.20, $0.05 better than the analyst estimate of $-0.25. Revenue for the quarter came in at $5.8M versus the consensus estimate of $6.73M.
Guidance
Clearpoint Neuro sees FY 2023 revenue of $23.00M-$25.00M versus the analyst consensus of $25.90M.
Clearpoint Neuro's stock price closed at $5.42. It is down -9.21% in the last 3 months and down -44.01% in the last 12 months.
Clearpoint Neuro saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Clearpoint Neuro's stock price’s past reactions to earnings here.
According to InvestingPro, Clearpoint Neuro's Financial Health score is "fair performance".
Check out Clearpoint Neuro's recent earnings performance, and Clearpoint Neuro's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar